Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients

NCT00701714 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.

NCT NCT00701714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00701714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients
Lead sponsor
Sandoz
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2007
Completion date
January 31, 2010
Enrollment
337 (actual)
Sites
123

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, chronic renal insufficiency